Tal Sines

Tal Sines has a wealth of experience in the business and science fields. Tal began their career in 2003 when they earned a Ph.D. in Life Science from the Weizmann Institute of Science. In 2009, they took on the role of Patent Associate at Teva Pharmaceuticals. In 2012, they became a Patent Attorney. From 2014 to 2017, they served as the IP Director of Hadasit - Hadassah Medical Organization. During this time, they were responsible for turning ideas and innovation into products and technologies. In 2017, they were appointed as the Chief Intellectual Property Officer of T3-Technion Technology Transfer. In 2018, they became the Co-Founder of DNAtix, a cutting-edge genetics and blockchain company. In 2019, they took on the role of Alliance Manager at CytoReason. Currently, Tal Sines is the Vice President of Business Development and Director of Business Development at Biond Biologics Ltd.

Tal Sines obtained a High School Diploma from Blich in 1991. Tal then attended Tel Aviv University from 1996 to 2000, earning a Bachelor of Science - BS. In 2000, they began their Master of Science - MS at Weizmann Institute of Science, which they completed in 2002. Tal then continued their education at Weizmann Institute of Science, earning a Ph.D in Life Science in 2007. In 2012, they completed a Patent Attorney course at the Israel Patent Office in Intellectual Property Law. In 2020, Tal Sines completed a Customer Success Course at pmsphere - Leading Products to Success.